Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 4th November 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pets at Home CEO to step down
"I have loved my time at Pets at Home" - Peter Pritchard, Pets at Home CEO.
Peter Pritchard will leave the company in May 2022 after more than a decade. 

Peter Pritchard has announced his intention to stand down from his role as chief executive officer and director of Pets at Home next summer.

In a press release, Pets at Home said Peter will remain in his role until late May 2022 ‘to ensure a smooth transition period’. It added that a search for a successor has commenced and a ‘further announcement will be made in due course’.

Peter joined Pets at Home in January 2011 and became group chief executive in 2018. 

Commenting on the announcement, he said: “I have loved my time at Pets at Home. It is a privilege to lead such a talented and passionate group of colleagues on this journey and I am incredibly proud of the results we have collectively achieved. 

“Having completed everything that I set out to achieve in 2018, next summer is the right time to take well-earned rest and to hand over the reins to a new leader who will continue this journey in becoming the Best Petcare Business in the World. 

“I would like to thank the Board for their support, and I look forward to maintaining the strong momentum in the business through the next few months and working with them to find and appoint a suitable successor.”

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.